Sedation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Sedation pipeline market research report provides comprehensive information on the therapeutics under development for Sedation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Sedation and features dormant and discontinued projects.
What are the key targets in the Sedation pipeline market?
The key targets in the Sedation pipeline market are Gamma-Aminobutyric Acid Receptor Subunit Alpha 1 (GABA), Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA), Gamma-Aminobutyric Acid Type A Receptor Subunit (GABA), Alpha 2 Adrenergic Receptor, Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Glutamate Ionotropic Receptor NMDA Type Subunit. Gamma-Aminobutyric Acid Receptor Subunit Alpha 1 (GABA) has the highest number of pipeline products in the Sedation pipeline market.
Sedation pipeline market, by target
For more target insights, download a free report sample
What are the key MoA in the Sedation pipeline market?
The key MoA in the Sedation pipeline market are Gamma-Aminobutyric Acid Receptor Subunit Alpha 1 (GABAAgonist), Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABAAgonist), Gamma-Aminobutyric Acid Type A Receptor Subunit (GABAAgonist), Alpha 2 Adrenergic Receptor Agonist, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, and Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist. Gamma-Aminobutyric Acid Receptor Subunit Alpha 1 (GABAAgonist) has the highest number of pipeline products.
Sedation pipeline market, by MoA
For more MoA insights, download a free report sample
What are the key RoA in the Sedation pipeline market?
The key RoA in the Sedation pipeline market are Intravenous, Nasal, Sublingual, Intravenous Bolus, and Oral. Intravenous has the highest number of pipeline products in the Sedation pipeline market.
Sedation pipeline market, by RoA
For more RoA insights, download a free report sample
What is the key molecule type in the Sedation pipeline market?
The key molecule type in the Sedation pipeline market is small molecule.
What is the key companies in the Sedation pipeline market?
The key companies in the Sedation pipeline market are PAION AG, Jiangsu Nhwa Pharmaceutical Co Ltd, Melt Pharmaceuticals Inc, Chengdu List Pharmaceutical Co Ltd, JOS Pharmaceuticals Ltd, Sichuan Haisco Pharmaceutical Co Ltd, and Sichuan Prime Pharmaceutical Co Ltd.
Sedation pipeline market, by companies
To know more about companies, download a free report sample
Market report overview
Key targets | Gamma-Aminobutyric Acid Receptor Subunit Alpha 1 (GABA), Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA), Gamma-Aminobutyric Acid Type A Receptor Subunit (GABA), Alpha 2 Adrenergic Receptor, Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Glutamate Ionotropic Receptor NMDA Type Subunit |
Key MoA | Gamma-Aminobutyric Acid Receptor Subunit Alpha 1 (GABAAgonist), Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABAAgonist), Gamma-Aminobutyric Acid Type A Receptor Subunit (GABAAgonist), Alpha 2 Adrenergic Receptor Agonist, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, and Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist |
Key RoA | Intravenous, Nasal, Sublingual, Intravenous Bolus, and Oral |
Key Molecule Type | Small Molecule |
Key Companies | PAION AG, Jiangsu Nhwa Pharmaceutical Co Ltd, Melt Pharmaceuticals Inc, Chengdu List Pharmaceutical Co Ltd, JOS Pharmaceuticals Ltd, Sichuan Haisco Pharmaceutical Co Ltd, and Sichuan Prime Pharmaceutical Co Ltd |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Sedation (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Sedation (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Sedation (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Sedation (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Sedation (Central Nervous System)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Sedation (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Sedation (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Jiangsu Nhwa Pharmaceutical Co Ltd
JOS Pharmaceuticals Ltd
Melt Pharmaceuticals Inc
PAION AG
Sichuan Haisco Pharmaceutical Co Ltd
Sichuan Prime Pharmaceutical Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Sedation pipeline market?
The key targets in the Sedation pipeline market are Gamma-Aminobutyric Acid Receptor Subunit Alpha 1 (GABA), Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA), Gamma-Aminobutyric Acid Type A Receptor Subunit (GABA, Alpha 2 Adrenergic Receptor, Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Glutamate Ionotropic Receptor NMDA Type Subunit.
-
What are the key MoA in the Sedation pipeline market?
The key MoA in the Sedation pipeline market are Gamma-Aminobutyric Acid Receptor Subunit Alpha 1 (GABAAgonist), Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABAAgonist), Gamma-Aminobutyric Acid Type A Receptor Subunit (GABAAgonist), Alpha 2 Adrenergic Receptor Agonist, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, and Glutamate Ionotropic Receptor NMDA Type Subunit Antagonist.
-
What are the key RoA in the Sedation pipeline market?
The key RoA in the Sedation pipeline market are Intravenous, Nasal, Sublingual, Intravenous Bolus, and Oral. Intravenous has the highest number of pipeline products in the Sedation pipeline market.
-
What is the key molecule type in the Sedation pipeline market?
The key molecule type in the Sedation pipeline market is small molecule.
-
What is the key companies in the Sedation pipeline market?
The key companies in the Sedation pipeline market are PAION AG, Jiangsu Nhwa Pharmaceutical Co Ltd, Melt Pharmaceuticals Inc, Chengdu List Pharmaceutical Co Ltd, JOS Pharmaceuticals Ltd, Sichuan Haisco Pharmaceutical Co Ltd, and Sichuan Prime Pharmaceutical Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.